Identity
HGNC
LOCATION
11p15.4
LOCUSID
ALIAS
BWR1A,BWSCR1A,HET,IMPT1,ITM,ORCTL2,SLC22A1L,TSSC5,p45-BWR1A
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 5002
MIM: 602631
HGNC: 10964
Ensembl: ENSG00000110628
Variants:
dbSNP: 5002
ClinVar: 5002
TCGA: ENSG00000110628
COSMIC: SLC22A18
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38366023 | 2024 | The effect of genetic variants of SLC22A18 on proliferation, migration, and invasion of colon cancer cells. | 0 |
| 38366023 | 2024 | The effect of genetic variants of SLC22A18 on proliferation, migration, and invasion of colon cancer cells. | 0 |
| 30635741 | 2019 | Knockdown of Orphan Transporter SLC22A18 Impairs Lipid Metabolism and Increases Invasiveness of HepG2 Cells. | 7 |
| 30635741 | 2019 | Knockdown of Orphan Transporter SLC22A18 Impairs Lipid Metabolism and Increases Invasiveness of HepG2 Cells. | 7 |
| 30145211 | 2018 | Involvement of an Orphan Transporter, SLC22A18, in Cell Growth and Drug Resistance of Human Breast Cancer MCF7 Cells. | 5 |
| 30145211 | 2018 | Involvement of an Orphan Transporter, SLC22A18, in Cell Growth and Drug Resistance of Human Breast Cancer MCF7 Cells. | 5 |
| 27402879 | 2016 | Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiers. | 10 |
| 27402879 | 2016 | Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiers. | 10 |
| 25498886 | 2015 | microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18. | 25 |
| 26196590 | 2015 | Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer. | 15 |
| 25498886 | 2015 | microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18. | 25 |
| 26196590 | 2015 | Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer. | 15 |
| 24481489 | 2014 | In vitro and in vivo radiosensitization of human glioma U251 cells induced by upregulated expression of SLC22A18. | 6 |
| 24481489 | 2014 | In vitro and in vivo radiosensitization of human glioma U251 cells induced by upregulated expression of SLC22A18. | 6 |
| 23514245 | 2013 | Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy. | 2 |
Citation
Dessen P
SLC22A18 (solute carrier family 22 member 18)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/42316/slc22a18
